Zweig Di Menna Associates LLC Verona Pharma PLC Transaction History
Zweig Di Menna Associates LLC
- $824 Million
- Q2 2025
A detailed history of Zweig Di Menna Associates LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Zweig Di Menna Associates LLC holds 74,250 shares of VRNA stock, worth $7.82 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
74,250Holding current value
$7.82 Million% of portfolio
0.85%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
302Shares Held
74MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$691 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$581 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$413 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$364 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$305 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.42B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...